Navigation Links
ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons
Date:12/9/2008

PLYMOUTH, Minn., Dec. 9 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market its EverCross 0.035" and NanoCross 0.014" peripheral angioplasty balloon catheters. ev3 expects to begin full commercialization of the EverCross and NanoCross peripheral balloon catheters globally in January 2009.

Robert Palmisano, ev3's president and chief executive officer commented, "We are looking forward to launching the EverCross and NanoCross balloons this January. Based on our experience to date, we believe both balloons will enhance customer ease of use and offer significantly better margins than our current distributed product. The ability to offer our own peripheral balloon catheter also provides access to key international markets, including Europe, where we do not currently sell balloons."

The EverCross and NanoCross peripheral balloon catheters are designed to offer improved overall performance in peripheral angioplasty procedures. Among several new features, both catheters offer innovative beveled tip profiles for best-in-class lesion entry and a broad range of sizes, including the only 200 mm length .035" balloon available worldwide. The EverCross balloons also offer Rated Burst Pressures that compete in the high pressure balloon market without compromising ease of use.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of peripheral vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a compr
'/>"/>

SOURCE ev3 Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kuvan Receives Marketing Approval in the European Union
2. Align Technology Receives Expanded Regulatory Approval in Japan
3. Adecco Receives Honor From Alcon Laboratories
4. ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
5. EastMed Inc. receives FDA clearance to market uresta(TM) in the U.S.
6. SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
7. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
8. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
9. Cellectricon Receives Milestone Order for Cellaxess(R)HT, the Worlds First High Throughput RNAi Screening System
10. China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
11. West Michigans Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 Convoy Therapeutics, Inc., a ... products to treat patients directly at the site ... SPACEā„¢ Technology Platform announced today that John Muraski, ... at the White Hat Life Science Investor Conferenceā„¢ ... Phoenix. In addition, interested individuals can meet ...
(Date:9/16/2014)... -- BCC Research reveals in its new ... the global market for stem cells is expected to ... five-year compound annual growth rate (CAGR) of 13.6%. The ... growth projections of $2.2 billion in 2014 to $3.9 ... Unlike other potential applications of bioscience, stem ...
(Date:9/15/2014)... Cancer Immunotherapy Market : ... Therapies is a new market research report announced ... principal types of therapeutics that have become the ... immunotherapy (which is often called "immuno-oncology") in recent ... cellular immunotherapy. , The regular use of ...
(Date:9/15/2014)... idea of fibers made of carbon nanotubes is neat, but ... The single-walled carbon nanotubes in new fibers created at Rice ... process designed by chemist Angel Mart and his colleagues. , ... results this month in the journal ACS Nano , ... together into a fiber. , Left to their own devices, ...
Breaking Biology Technology:Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 2Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5Rice rolls 'neat' nanotube fibers 2Rice rolls 'neat' nanotube fibers 3
... /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products Group Corporation (OTC Bulletin ... products sold during the fourth,quarter of 2007 strengthened ... over the same period in the previous year., ... is a joint-venture of Kiwa,and Tianjin Challenge Feed ...
... Tengion Inc., a clinical,stage regenerative medicine company ... today that Steven Nichtberger, M.D.,President and Chief Executive ... Pharmaceutical, Biotechnology and Medical Device Conference on,Tuesday, February ... will be held at,the Grand Hyatt Hotel in ...
... Inc. (OTC Bulletin Board: CARN) said it retained,Milkie/Ferguson ... it in,exploring a range of financial alternatives., ... continuation of our efforts to,thoroughly consider our business ... PhD, chief executive officer of Carrington.,"We have valuable ...
Cached Biology Technology:Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007 2Carrington Retains Milkie/Ferguson to Explore Financial Alternatives 2
(Date:9/15/2014)... evolved a simple, mechanical solution to avoid chromosome ... Science Express. , This ... that lead to infertility, miscarriage, or congenital conditions. ... these problems, but what exactly goes wrong is ... Wellcome Trust Center for Cell Biology at the ...
(Date:9/15/2014)... containing carbon-halogen bonds are produced naturally across all kingdoms ... products with a broad range of biological activities. The ... a profound influence on their molecular properties. ... has been to find the late-stage, site-specific incorporation of ... replacing an sp C-H bond (one of the most ...
(Date:9/15/2014)... results will allow us to better understand how ... change scenarios and provide the type of environmental ... management and siting of protected areas," said Paula ... for Coastal Ocean Science (NCCOS) and lead author ... lie within the temperate-tropical transition zone, where historically, ...
Breaking Biology News(10 mins):Cells simply avoid chromosome confusion 2Cells simply avoid chromosome confusion 3Pitt chemical biologist finds new halogenation enzyme 2Study finds warming Atlantic temperatures could increase range of invasive species 2
... how compound word formation is influenced by subtle forms ... to the speakers of a language have a higher ... words are subject to selection pressures that play a ... language over time. The study, "Grammars leak: Modeling ...
... ARLINGTON, Va.Underscoring the importance of alternative energy for the ... Corps Base Hawaii Dec. 7 to learn about possible ... Research (ONR)-funded fuel cell vehicles (FCV) and high-efficiency trash ... the 70th anniversary of the Pearl Harbor attack, was ...
... bees and brains made up of neurons make decisions using ... 9 issue of Science . In previous work, ... a honeybee swarm perform "waggle dances" to prompt other scout ... In the new study, Seeley, a professor of ...
Cached Biology News:Survival of the fittest: Linguistic evolution in practice 2New energy sources fuel interest from Secretary of the Navy 2
IgD Chain C (AMS 9.1)...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
... 9001:2000 Certified USDA Research Registered OLAW Assured ... Training AALAS Certified Technicians Documentation ... Documentation Upon Request Focus CRP ... all your custom immunology service needs. ...
Biology Products: